Dermatomyositis and polymyositis (myositis) trials in Lithuania

1 of 1 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Enrolling by invitation
  A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

  Where

  Kaunas, Vilnius

  Age

  18 years and over

  People

  240 worldwide

  Run by

  argenx

  See details and how to joinNCT05979441 · EU 2022-502851-79-00